CRY stock forecast
Our latest prediction for CryoLife, Inc.'s stock price was made on the Nov. 13, 2019 when the stock price was at 23.39$.
In the short term (2weeks), CRY's stock price should outperform the market by 2.10%. During that period the price should oscillate between -4.90% and +6.27%.
In the medium term (3months), CRY's stock price should outperform the market by 2.71%. During that period the price should oscillate between -12.42% and +16.16%.Get email alerts
Create a solid portfolio with CRY
About CryoLife, Inc.
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.
At the moment the company generates 258M USD in revenues.
On its last earning announcement, the company reported a loss of -0.28$ per share.
The book value per share is 7.38$
Three months stock forecastNov. 13, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|